Viewing Study NCT00743132


Ignite Creation Date: 2025-12-24 @ 9:56 PM
Ignite Modification Date: 2025-12-25 @ 7:34 PM
Study NCT ID: NCT00743132
Status: COMPLETED
Last Update Posted: 2010-01-25
First Post: 2008-08-27
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Novel Prediction Score for Postoperative Acute Renal Failure (ARF) Following Liver Resection
Sponsor: University of Zurich
Organization:

Study Overview

Official Title: Novel Prediction Score for Postoperative Acute Renal Failure (ARF) Following Liver Resection
Status: COMPLETED
Status Verified Date: 2010-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: StV 11-2008
Brief Summary: ARF is a frequent event after hepatic resection and therefore clinically highly relevant.

There is limited evidence on the incidence of postoperative ARF and its clinical relevance in patients undergoing liver resection.

This study will evaluate the incidence of acute renal failure (ARF) after liver resection and its impact on postoperative mortality.
Detailed Description: ARF is a frequent event after hepatic resection and therefore clinically highly relevant.

There is limited evidence on the incidence of postoperative ARF and its clinical relevance in patients undergoing liver resection.

This study will evaluate the incidence of acute renal failure (ARF) after liver resection and its impact on postoperative mortality.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
StV 11-2008 None None View